Switch to:
GuruFocus has detected 4 Warning Signs with AbbVie Inc $ABBV.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
AbbVie Inc (NYSE:ABBV)
Cash Flow from Financing
$-4,503 Mil (TTM As of Mar. 2017)

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Mar. 2017, AbbVie Inc paid $895 Mil more to buy back shares than it received from issuing new shares. It received $17 Mil from issuing more debt. It paid $0 Mil more to buy back preferred shares than it received from issuing preferred shares. It spent $1,027 Mil paying cash dividends to shareholders. It received $111 Mil on other financial activities. In all, AbbVie Inc spent $1,794 Mil on financial activities for the three months ended in Mar. 2017.


Definition

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

AbbVie Inc's Cash from Financing for the fiscal year that ended in Dec. 2016 is calculated as:

Cash from Financing(A: Dec. 2016 )
=Net Issuance of Stock+Net Issuance of Debt+Net Issuance of Preferred+Dividends+Other Financing
=-6033+5588+0+-3717+234
=-3,928

AbbVie Inc's Cash from Financing for the quarter that ended in Mar. 2017 is

Cash from Financing(Q: Mar. 2017 )
=Net Issuance of Stock+Net Issuance of Debt+Net Issuance of Preferred+Dividends+Other Financing
=-895+17+0+-1027+111
=-1,794

AbbVie Inc Cash Flow from Financing for the trailing twelve months (TTM) ended in Mar. 2017 was 1164 (Jun. 2016 ) + -1371 (Sep. 2016 ) + -2502 (Dec. 2016 ) + -1794 (Mar. 2017 ) = $-4,503 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Explanation

Cash from financing contains five items:

1. Net Issuance of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. If this number is positive, it means that the company has received more cash from issuing shares than it has paid to buy back shares. If this number is negative, it means that company has paid more cash to buy back shares than it has received for issuing shares.

AbbVie Inc's net issuance of stock for the three months ended in Mar. 2017 was $-895 Mil. AbbVie Inc paid $895 Mil more to buy back shares than it received from issuing new shares.

2. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

AbbVie Inc's net issuance of debt for the three months ended in Mar. 2017 was $17 Mil. AbbVie Inc received $17 Mil from issuing more debt.

3. Net Issuance of Preferred:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

AbbVie Inc's net issuance of preferred for the three months ended in Mar. 2017 was $0 Mil. AbbVie Inc paid $0 Mil more to buy back preferred shares than it received from issuing preferred shares.

4. Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

AbbVie Inc's cash flow for dividends for the three months ended in Mar. 2017 was $-1,027 Mil. AbbVie Inc spent $1,027 Mil paying cash dividends to shareholders.

5. Other Financing:
Money spent or earned by company from other financial activities.

AbbVie Inc's other financing for the three months ended in Mar. 2017 was $111 Mil. AbbVie Inc received $111 Mil on other financial activities.


Related Terms

Cash Flow from Operations, Cash Flow from Investing, Net Issuance of Stock, Net Issuance of Debt, Dividends, Net Issuance of Preferred


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

AbbVie Inc Annual Data

Dec09Dec10Dec11Dec12Dec13Dec14Dec15Dec16
Net Issuance of Stock 000000-320-665-7,586-6,033
Net Issuance of Debt 0000015,586-601-516,6235,588
Net Issuance of Preferred 0000000000
Dividends 000000-2,555-2,661-3,294-3,717
Other Financing 00000-13,65534389234
Cash from Financing 00-4,88165-6,7831,931-3,442-3,2935,752-3,928

AbbVie Inc Quarterly Data

Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16Dec16Mar17
Net Issuance of Stock -313-342-5,002-998-1,244-409-3,8033-1,824-895
Net Issuance of Debt 10714416,075761-357-65,860-49522917
Net Issuance of Preferred 0000000000
Dividends -674-786-818-850-840-924-927-933-933-1,027
Other Financing -254-863110120345426111
Cash from Financing -882-93010,169-1,056-2,431-1,2191,164-1,371-2,502-1,794
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK